Streetbeat News

Products Services

UPWK

Upwork has introduced a new suite of generative AI apps, offers, and educational content for independent professionals. The move is aimed at enhancing the platform's capabilities and providing more value to its users.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:06 pm

VECO

Veeco Instruments Inc. has shipped its first NSA500 Nanosecond Annealing System to a Tier 1 logic customer, marking a significant step in its leadership in advanced laser annealing technology. The NSA500 is designed for low thermal budget and material modification applications, crucial for advanced node and 3D applications. Veeco plans to ship its second evaluation system to another Tier 1 customer in the coming months and anticipates initial high-volume manufacturing orders in late 2024 or 2025.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:06 pm

IINN

IINNW

Inspira Technologies has received a grant from the Israeli Innovation Authority (IIA) for its VORTX Disposable Blood Oxygenation Technology. The VORTX technology, which is being designed for compatibility with the INSPIRA ART Device line of products, is a potential frontrunner in the $4 billion disposable blood oxygenator market. The IIA has committed to supporting the VORTX development project by granting funds equal to 40% of the first-year IIA approved budget of $1 million.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:05 pm

ANSS

MTLS

Ansys (NASDAQ: ANSS) and Materialise (NASDAQ: MTLS) have announced a strategic partnership to deliver integrated digital solutions to address workflow challenges in the additive manufacturing (AM) industry. The partnership will integrate Ansys Additive Suite into Materialise's data and build preparation tool, Magics. The initial solution, to be previewed at Formnext 2023 and arriving in Q2 2024, will provide a workflow for managing AM industrial projects across industries, including the medical and aerospace sectors.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:02 pm

MRK

SLS

SELLAS Life Sciences presented data from a Phase 1/2 trial of Galinpepimut-S in combination with Keytruda in WT1+ Platinum-Resistant Advanced Ovarian Cancer at the International Gynecologic Cancer Society 2023 Annual Global Meeting. The combination treatment showed a median overall survival of 18.4 months, compared to 13.8 months in a Keytruda single agent study and 11-14 months with standard of care chemotherapy. The combination also yielded a WT1-specific T-cell immune response and correlated positively in a subset of patients with IFNγ and MIP1β biomarkers.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:00 pm

IBM

Riyadh Air and IBM have signed a strategic agreement where IBM Consulting will be the lead systems integrator to support the creation, building, and orchestration of the technology foundation for the digitally native airline. The collaboration aims to position Riyadh Air strategically within the broader ecosystem to offer digital innovations and exceptional experiences for travelers. IBM Consulting will also establish and maintain Riyadh Air's hybrid cloud integration platform.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:59 pm

COMM

STM

CommScope (NASDAQ:COMM) and STMicroelectronics (NYSE:STM) have announced the integration of CommScope's PKIWorks IoT security platform with ST's STM32WB microcontroller unit. This solution simplifies the development and provisioning of secure IoT devices that meet the Connectivity Standards Alliance's Matter standard for security. The collaboration leverages CommScope's experience in integrating cryptographic keys and digital certificates into high-volume manufacturing production and ST's leadership in microcontrollers.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:54 pm

HAL

OIS

Halliburton and Oil States Industries have collaborated to provide innovative deepwater Managed Pressure Drilling solutions. This collaboration will streamline the installation of all aspects of the deepwater Managed Pressure Drilling equipment, control systems, and services.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:52 pm

PLRX

Pliant Therapeutics, Inc. (NASDAQ:PLRX) presented three posters at the 38th Annual Meeting of the Society for Immunotherapy of Cancer, highlighting PLN-101095, a novel inhibitor of integrins αvβ8 and αvβ1. The company is conducting a Phase 1a trial of PLN-101095 as monotherapy and in combination with pembrolizumab in treatment-resistant patients with advanced or metastatic solid tumors. The inhibitor was also shown to decrease primary tumor growth and improve chemosensitivity in preclinical models of pancreatic ductal adenocarcinoma.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:52 pm

CRSP

CRISPR Therapeutics AG (NYSE:CRSP) shares are trading higher after the company announced preclinical data for its investigational programs for the treatment of cardiovascular disease. The data, set to be presented at the American Heart Association (AHA) Scientific Sessions 2023, covers CTX310 and CTX320, which have been found to reduce ANGPTL3 protein and lipoprotein(a) levels respectively in non-human primates after a single dose.

Portfolio Pulse from Adam Eckert

November 06, 2023 | 1:51 pm